日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies

肥胖的遗传蓝图:从发病机制到新型疗法

Tonin, Gašper; Eržen, Stjepan; Mlinarič, Zala; Eržen, Dubravka Jurišić; Horvat, Simon; Kunej, Tanja; Klen, Jasna

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice

钠-葡萄糖协同转运蛋白2和胰高血糖素样肽-1受体的遗传变异对2型糖尿病患者在日常临床实践中接受SGLT2抑制剂和GLP-1RA治疗时血糖和血压控制的影响

Tonin, Gašper; Goričar, Katja; Blagus, Tanja; Janež, Andrej; Dolžan, Vita; Klen, Jasna

Erectile Dysfunction in Diabetes Mellitus: A Comprehensive Narrative Review of Pathophysiology, Genetic Association Studies and Therapeutic Approaches

糖尿病合并勃起功能障碍:病理生理学、遗传关联研究和治疗方法的综合叙述性综述

Hostnik, Boštjan; Tonin, Gašper; Janež, Andrej; Klen, Jasna

Genetic and Transcriptomic Background of Oxidative Stress and Antioxidative Therapies in Late Complications of Type 2 Diabetes Mellitus: A Systematic Review

2型糖尿病晚期并发症中氧化应激和抗氧化疗法的遗传和转录组学背景:系统评价

Tonin, Gašper; Dolžan, Vita; Klen, Jasna

Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity

胰淀素,另一种用于治疗糖尿病肥胖症的重要神经内分泌激素

Eržen, Stjepan; Tonin, Gašper; Jurišić Eržen, Dubravka; Klen, Jasna

SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation

SGLT2抑制剂在糖尿病肾病治疗中的应用:不仅仅是调节血糖

Klen, Jasna; Dolžan, Vita

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice

依替巴肽:一种具有新适应症的经典治疗肽——从临床药理学到日常临床实践

Tonin, Gašper; Klen, Jasna

Monitoring the effect of perioperative nutritional care on body composition and functional status in patients with carcinoma of gastrointestinal and hepatobiliary system and pancreas

监测围手术期营养护理对胃肠道、肝胆系统和胰腺癌患者身体成分和功能状态的影响

Gyergyek, Andrej; Rotovnik Kozjek, Nada; Klen, Jasna

The associations of PON1 and APOE polymorphisms with plasma lipid levels and the risk for late complications in type 2 diabetes patients

PON1和APOE多态性与血浆脂质水平及2型糖尿病患者晚期并发症风险的关联

Klen, Jasna; Goričar, Katja; Dolžan, Vita

Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors

胰高血糖素样肽-1受体激动剂在2型糖尿病和肥胖症治疗中的应用:药理学特性和遗传因素的影响

Klen, Jasna; Dolžan, Vita